Speaker Profile

Ph.D., Assoc. Prof., College of Clinical Pharmacy, King Faisal University

Dr Akrawi works in the field of biopharmaceutics and clinical pharmacokinetics, focused on bioavialability and bioequivalency studies for different molecules of drugs, drug-drug interaction, food-drug interaction, effects of drugs and some herbs on kidney and liver function, teaching and supervise under and post graduate pharmacy students. Dr Akrawi did researches in the stereoselective disposition of drugs and perform the portal continuous infusion of medication in unrestrained animal to study the stereoselective disposition of drugs and the effect of liver enzyme in the process. His PhD is from the college of pharmacy University of Kentucky.

Clinical & Research Tools Showcase:
King Faisal University

College of Clinical Pharmacy accredited by the American ACPE and Canadian CCAPP, Its program is to graduate Pharm D Pharmacist.

Development And Evaluation Of Mucoadhesive Buccal Film Of Almotriptan To Improve The Therapeutic Delivery
The aim of present investigation was to formulate oral mucoadhesive film of almotriptan to improve the drug delivery and desired therapeutic effects. Physicomechanical and pharmaceutical characteristics of drug loaded films (FA1-FA4) were examined. Selected FA4 film was evaluated in vivo by assessing the pharmacokinetic profile and compared with oral therapy in rabbits. In vivo data demonstrated rapid and efficient absorption (p<0.005) of almotriptan with greater AUC0-12 (>2 folds, p<0.0001) by FA4 film as compared to oral (control). Data established the potential of FA4 film to improve the therapeutic delivery of almotriptan and offers a promising option in migraine therapy.

 Session Abstract – PMWC 2020 Silicon Valley

The PMWC 2020 Clinical & Research Tools Showcase will provide a 15-minute time slot for selected companies in this space. The Clinical & Research Tools is a showcase for innovative technologies that are used for the analysis of genetic variation and function, helping to advance breakthroughs in genetic health, rare disease conditions on individuals of all ages, complex diseases and cancer care. Next-generation sequencing (NGS) and microarray technologies empower rapidly evolving genomic revolution.